Prospective Clinical Observational Cohort Study to Evaluate the Use of a Tissue Separating Mesh (Proceed®) in Laparoscopic Ventral Hernia Repair

Prospective Clinical Observational Cohort Study to Evaluate the Use of a Tissue Separating Mesh (Proceed®) in Laparoscopic Ventral Hernia Repair

1. General: antibiotic prophylaxis: cefazoline (Cefacidal™) 2 gram iv administered 30 minutes before surgery

2. Laparoscopic surgery

   • at least 5 cm overlap (mesh diameter should exceed hernia size by at least 10 cm)
   • with or without anchoring transparietal sutures or double crown technique

Inclusion Criteria:

• written informed consent from the patient or his/her legal representative
• ventral hernia requiring elective surgical repair

Exclusion Criteria:

• no written informed consent
• 'hostile' abdomen; open abdomen treatment
• contraindication to pneumoperitoneum
• emergency surgery (incarcerated hernia)
• parastomal hernia